CMP: 717

Cadila Healthcare Ltd. manufactures, and markets healthcare solutions ranging from formulations, active pharmaceutical ingredients, vaccines, diagnostics, health and dietetic foods, animal healthcare to cosmeceuticals. The Company's products are available in tablets, capsules, injections, liquids, dry syrups, powders, granules, and ointments.

Cadila Healthcare is a good bet in budding large-cap space. Its currently trading at a P/E of 24 with decent dividend yields of close to 1% in the last 12 months. Minimal liability. Revenues have risen from 1246 Crores to 2919 Crores in a steady fashion in the last 5 years. Profits have risen more from 166 Crores to 610 Crores over 5 years. NPM has grown strongly from 13% to 21% over 5 years. Buy and hold for long term gains.